3SBio Inc.

Status: Publicly traded

Direct answer

3SBio Inc. is publicly traded on HKSE under the ticker 1530.HK.

Operating as an investment holding company, 3SBio Inc. specializes in the full lifecycle of biopharmaceutical products within the People's Republic of China, encompassing research, development, manufacturing, marketing, and sales. Its diverse portfolio addresses a range of medical needs. Key therapeutic agents include TPIAO, a recombinant human thrombopoietin for chemotherapy-induced and immune thrombocytopenia;...

Can you invest in 3SBio Inc.?

Yes. 3SBio Inc. trades publicly on HKSE as 1530.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for 3SBio Inc.

Detailed equity research is provided by MarketSnap.